Bioxytran completes production of two dietary supplements
BIXT•Bioxytran completed production of V-LO and A-SUQAR and is building finished inventory ahead of commercialization. Launch timing remains subject to finalized marketing and sales plans.
1. Production completed
Bioxytran completed production of V-LO for immune support and A-SUQAR for healthy blood sugar support, building finished inventory ahead of commercialization. Marketing and sales plans across e-commerce, retail and distribution channels are being finalized, and launch timing remains subject to those plans. A February 2026 distribution agreement with Khoury Medical covers A-SUQAR commercialization in the Middle East.
2. Market projections
The global immune health supplements market is projected to reach $67.79 billion by 2032, with 9.12% compound annual growth. The global glucose management supplements market is projected to reach $15.4 billion by 2032, with 6.4% compound annual growth.
